Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart inflammation seen in some patients 2 months after vaccination | Early menopause & TAVR outcomes
Friday, March 10, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Heart inflammation remains 2 months later in some patients with COVID-19 vaccine-related myocarditis

A team of cardiologists and radiologists collaborated on the study, using advanced imaging to take a closer look at the long-term impact of vaccination. 

READ MORE >
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
Share on Twitter Share on Facebook Share on Linkedin

Heart inflammation remains 2 months later in some patients with COVID-19 vaccine-related myocarditis

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
A team of cardiologists and radiologists collaborated on the study, using advanced imaging to take a closer look at the long-term impact of vaccination. 
READ MORE >

Poor mental health leads to higher CVD risk in young adults

Even among people who do not experience any major cardiovascular events, researchers noted, there are strong associations between poor mental health and poor heart health.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Poor mental health leads to higher CVD risk in young adults

Share on Twitter Share on Facebook Share on Linkedin
Even among people who do not experience any major cardiovascular events, researchers noted, there are strong associations between poor mental health and poor heart health.
READ MORE >

What new data tell us about TAVR in women with a history of early menopause

Researchers examined data from more than 700 TAVR patients, publishing their findings in the American Journal of Cardiology.

READ MORE >
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Share on Twitter Share on Facebook Share on Linkedin

What new data tell us about TAVR in women with a history of early menopause

Share on Twitter Share on Facebook Share on Linkedin
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Researchers examined data from more than 700 TAVR patients, publishing their findings in the American Journal of Cardiology.
READ MORE >

Featured Articles

Cardiologists warn Biden administration that new policies could put PAD patients at risk

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

READ MORE >
a patient talks with her doctor, both are women of color
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists warn Biden administration that new policies could put PAD patients at risk

Share on Twitter Share on Facebook Share on Linkedin
a patient talks with her doctor, both are women of color
SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 
READ MORE >

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

READ MORE >
Hospital Costs
Share on Twitter Share on Facebook Share on Linkedin

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

Share on Twitter Share on Facebook Share on Linkedin
Hospital Costs
SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 
READ MORE >

ACC.23 emerges as a return to normalcy for the cardiology community

Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic. 

READ MORE >
An attendee tries out a hands-on TEE simulator in a packed GE Healthcare booth at ACC.23. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

ACC.23 emerges as a return to normalcy for the cardiology community

Share on Twitter Share on Facebook Share on Linkedin
An attendee tries out a hands-on TEE simulator in a packed GE Healthcare booth at ACC.23. Photo by Dave Fornell
Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic. 
READ MORE >

In Case You Missed It

FDA warns that early deterioration is possible with Abbott’s Trifecta heart valves

Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.

READ MORE >
Abbott and the U.S. Food and Drug Administration (FDA) are warning healthcare providers about the potential risk of early structural valve deterioration (SVD) with Abbott’s line of Trifecta bioprosthetic heart valves. This includes the original Trifecta valve and the Trifecta GT, which are both designed to treat disease, damaged or malfunctioning aortic heart valves.
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that early deterioration is possible with Abbott’s Trifecta heart valves

Share on Twitter Share on Facebook Share on Linkedin
Abbott and the U.S. Food and Drug Administration (FDA) are warning healthcare providers about the potential risk of early structural valve deterioration (SVD) with Abbott’s line of Trifecta bioprosthetic heart valves. This includes the original Trifecta valve and the Trifecta GT, which are both designed to treat disease, damaged or malfunctioning aortic heart valves.
Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.
READ MORE >

New direct wire pacing device shows potential during PCI and TAVR, first-in-human study finds

Early evidence suggests the Electroducer Sleeve is safe and effective among patients presenting for certain interventional procedures. 

READ MORE >
ElectroDucer Sleeve PCI TAVR EuroIntervention
Share on Twitter Share on Facebook Share on Linkedin

New direct wire pacing device shows potential during PCI and TAVR, first-in-human study finds

Share on Twitter Share on Facebook Share on Linkedin
ElectroDucer Sleeve PCI TAVR EuroIntervention
Early evidence suggests the Electroducer Sleeve is safe and effective among patients presenting for certain interventional procedures. 
READ MORE >

In Other News

FDA to require breast-density notifications from mammography facilities

The administration also is strengthening its ability to oversee imaging providers and enforce standards in the Mammography Quality Standards Act. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA to require breast-density notifications from mammography facilities

Share on Twitter Share on Facebook Share on Linkedin
The administration also is strengthening its ability to oversee imaging providers and enforce standards in the Mammography Quality Standards Act. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme